In this article
Body composition analysis can support metabolic health care by showing changes in fat, muscle, and visceral adiposity that weight and BMI alone cannot distinguish. Tracking these changes helps clinicians evaluate the quality of weight change, personalize care, and explain progress beyond the scale.[1,2]
Here’s an overview based on insights from Michael Glickman, MD, a physician board-certified in family medicine, obesity medicine, and lifestyle medicine, and founder of Revolution Medicine, Health & Fitness.[1]
Weight measures total body mass, but it does not distinguish fat from muscle or show where fat is stored.
Dr. Glickman explains that two patients can weigh the same yet have different proportions of muscle, fat, and water. Similarly, weight loss can include changes in several compartments. Understanding those changes adds context to whether a treatment plan is meeting its goals.[1]
Body composition provides information about fat and muscle that BMI, a calculation based on height and weight, does not separate.[2] Dr. Glickman focuses on a few measures that tell the clearest clinical story rather than reviewing every metric on a report.[1]
Fat mass and body fat percentage help describe how much fat a patient has and how that amount or proportion changes over time.[2]
Estimated skeletal muscle mass helps track muscle during weight loss or other interventions. It doesn’t measure strength or function; those require separate assessment.[1]
Dr. Glickman also distinguishes muscle from fat-free mass, which includes water, organs, bone mineral content and other nonfat tissues.[1]
Visceral adipose tissue is fat surrounding abdominal organs, situated within the intra-abdominal cavity. Excess visceral adiposity is associated with cardiovascular risk beyond what BMI alone captures, as described in an American Heart Association scientific statement.[3]
Dr. Glickman explains that GLP-1s are powerful tools for obesity and metabolic care, but weight loss can also include loss of muscle. Monitoring body composition can help clinicians evaluate whether patients are losing fat while preserving muscle and can help guide conversations around nutrition, resistance training, and treatment. [1,5]
One patient is described whose follow-up assessment showed declining estimated muscle mass. After discussions about protein intake and strength training, a later assessment showed improvement. This example illustrates how body composition trends can help inform the clinical conversation.[1]
A multi-society advisory on GLP-1 care also emphasizes adequate nutrition, protein intake, and strength training to support lean mass preservation.[5]
Changes over time can help clinicians identify what needs closer review in a patient’s nutrition, activity, or treatment plan.
Dr. Glickman uses serial measurements to evaluate the quality of change and inform discussions about:
Focus on a few relevant measures instead of every metric available, explain why they matter, and relate trends to the patient’s goals.[1] Dr. Glickman recommends keeping the conversation simple:
Celebrate progress beyond weight
Discuss favorable composition trends alongside changes in function and clinical markers. These conversations can help patients understand the purpose of nutrition and exercise recommendations, even when weight changes slowly.[1]
Measurement frequency should depend on the patient, treatment, and whether the results would inform care.
Dr. Glickman establishes a baseline for new patients and commonly reassesses quarterly. He describes more frequent follow-up for some patients, with flexibility based on their needs and preferences.[1] In his practice, Dr. Glickman treats body composition similarly to another clinical vital sign.[1]
Yes. It can reveal favorable fat and muscle trends when total weight changes little.
In the webinar, Dr. Glickman describes a patient who felt frustrated after losing only about three pounds over six months. Body composition assessments showed a different pattern: higher estimated muscle mass, lower body fat, and reduced visceral adiposity.
Those findings changed the conversation. Instead of assuming treatment had stopped working, the results were used to explain progress and continue the existing plan. The example shows how body composition can provide important context when the scale alone suggests little progress.[1]
Use it alongside clinical history, labs, medication follow-ups, nutrition counseling, and exercise planning.
A practical workflow is to establish a baseline, repeat assessments when useful, and review the trends with relevant markers such as A1C, lipids, blood pressure, and physical function.[1]
seca’s medical body composition analysis can support this approach by helping clinicians track estimated fat, skeletal muscle, and visceral adiposity over time. The seca Metabolic Health Results Guide explains these parameters, while its Functional and Integrative Medicine resources explore their use in practice.[2,7]
Watch the full webinar with Dr. Michael Glickman to learn how he uses body composition in metabolic and obesity care, communicates results with patients, and integrates BIA into his clinical workflow.[1]
Body composition analysis assesses the tissues and compartments that make up body weight such as fat, muscle, and body water. Bioelectrical impedance analysis, or BIA, uses electrical measurements and prediction equations to estimate these components of body composition.[1]
BMI relates weight to height. Body composition adds information about fat and muscle, helping clinicians understand what may be changing within total weight.[2]
Maintaining muscle preserves metabolic rate and supports physical function. Tracking estimated muscle mass can help clinicians review nutrition and exercise needs, alongside direct assessments of strength and function.[1,5]
Excess visceral adiposity, or VAT, is associated with cardiometabolic risk. Monitoring VAT can add context to risk assessment when interpreted with waist circumference, labs, blood pressure, and clinical history.[3,4]
Use an individualized schedule. Dr. Glickman commonly measures at baseline and quarterly, but the appropriate interval depends on the patient’s treatment and clinical needs.[1]
Yes. It can help track fat and muscle trends during treatment and support discussions about nutrition, strength training, and treatment response.[1,5]
Medical Measuring Systems and Scales since 1840
13601 Benson AvenueAs the world leader in medical scales, we also offer you first-class service. Together with our branches, partners and dealers, seca offers a worldwide service network that ensures our products work troublefree.
All rights reserved seca 2023